What are the clinical features and treatment of Legionella pneumonia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Legionella pneumonia is a severe respiratory infection that requires immediate treatment with macrolides or fluoroquinolones, with azithromycin being the first-line therapy, to reduce morbidity, mortality, and improve quality of life. The clinical features of Legionella pneumonia include high fever, cough, shortness of breath, headache, myalgia, and gastrointestinal symptoms like diarrhea, nausea, and vomiting, as well as hyponatremia, elevated liver enzymes, and potential neurological symptoms 1. Diagnosis is confirmed through urine antigen testing, sputum culture, or PCR, with the urinary antigen assay being the preferred diagnostic test due to its high sensitivity and specificity 1.

Clinical Features and Diagnosis

The clinical features of Legionella pneumonia can be non-specific, making diagnosis challenging, but a combination of clinical and laboratory findings can help guide diagnosis 1. The disease is acquired by inhaling aerosolized water containing the bacteria, often from cooling towers, showers, or hot tubs, not through person-to-person transmission 1.

Treatment and Management

Treatment with azithromycin (500mg IV daily for 7-10 days, then oral if improving) or levofloxacin (750mg daily for 7-14 days) should be initiated as soon as possible to reduce mortality and improve outcomes. For severe cases, combination therapy with azithromycin plus levofloxacin or rifampin may be considered 1. Hospitalization is often necessary, with ICU care for respiratory failure, and treatment should be started immediately upon suspicion, as delayed therapy increases mortality 1.

Prevention and Control

Prevention of Legionella pneumonia involves avoiding exposure to contaminated water sources, such as cooling towers, showers, and hot tubs, and ensuring proper maintenance and disinfection of these systems 1. Smoking cessation should also be a goal for persons hospitalized with CAP who smoke, as smoking is a risk factor for Legionella pneumonia 1.

Quality of Life and Outcomes

Complete recovery from Legionella pneumonia may take several weeks to months, with fatigue often persisting after other symptoms resolve 1. Prompt treatment with effective antibiotics, such as azithromycin or levofloxacin, can improve quality of life and reduce morbidity and mortality associated with Legionella pneumonia.

From the FDA Drug Label

For both studies, the clinical success rate in patients with atypical pneumonia due to Chlamydophila pneumoniae, Mycoplasma pneumoniae, and Legionella pneumophila were 96%, 96%, and 70%, respectively. Levofloxacin tablets are indicated for the treatment of community-acquired pneumonia due to methicillin-susceptible Staphylococcus aureus, Streptococcus pneumoniae (including multi-drug-resistant Streptococcus pneumoniae [MDRSP]), Haemophilus influenzae, Haemophilus parainfluenzae, Klebsiella pneumoniae, Moraxella catarrhalis, Chlamydophila pneumoniae, Legionella pneumophila, or Mycoplasma pneumoniae

The clinical features of Legionella pneumonia are not explicitly described in the provided drug labels. However, the labels do mention that levofloxacin is indicated for the treatment of community-acquired pneumonia due to Legionella pneumophila, with a clinical success rate of 70% 2.

  • The treatment of Legionella pneumonia with levofloxacin is supported by the drug labels, which indicate that levofloxacin is effective against this pathogen 2, 2.
  • Key points to consider when treating Legionella pneumonia with levofloxacin include the clinical success rate and the importance of selecting antibacterial therapy based on susceptibility testing 2.

From the Research

Clinical Features of Legionella Pneumonia

  • Legionella pneumophila is a common cause of community-acquired pneumonia in patients who require intensive care unit (ICU) admission 3
  • The clinical manifestations of Legionnaires' disease are often more severe and have a higher mortality rate compared to pneumonias of other etiologies 3
  • Symptoms of Legionella pneumonia may include high fever, diarrhea, mental status changes, and hyponatremia 3
  • Legionnaire's disease can have several presenting signs, symptoms, and laboratory abnormalities, but none are sufficient to distinguish L pneumophila pneumonia from other respiratory pathogens 4

Diagnosis of Legionella Pneumonia

  • Urinary antigen testing and culture on selective media are recommended for diagnosing Legionnaires' disease 3
  • PCR in respiratory samples has been shown to have excellent diagnostic performance and is preferable to urinary antigen testing 5
  • The diagnostic accuracy of PCR in various clinical samples has been assessed, and it has been found to have high sensitivity and specificity values for diagnosing Legionella pneumonia 5

Treatment of Legionella Pneumonia

  • Antibiotics that efficiently enter the intracellular space, such as macrolides or fluoroquinolones, are recommended for treating Legionella pneumonia 4
  • Levofloxacin and azithromycin have been compared as treatments for community-acquired legionella pneumonia, and no significant differences in outcomes were found between the two 6
  • Low-spectrum antibiotic therapy based on urinary antigen tests has been shown to be efficient in treating community-acquired pneumonia, including Legionella pneumonia 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Legionella as a cause of severe pneumonia.

Seminars in respiratory and critical care medicine, 2000

Research

Levofloxacin versus azithromycin for treating legionella pneumonia: a propensity score analysis.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.